Showing results (131-140 of 302) with videos related to

Sort By:
Pageof 31
The Lancet. Haematology|June 6, 2024
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trialJillian R Gunther, Jie Xu, Manoop S Bhutani, et al.
American Journal of Clinical Oncology|September 4, 2019
Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell TherapyHamzah Abu-Sbeih, Tenglong Tang, Faisal S Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigenSattva S Neelapu, Sivasubramanian Baskar, Barry L Gause, et al.
Multiple Sclerosis and Related Disorders|January 28, 2021
Primary mediastinal large B-cell lymphoma in a patient on Fingolimod for relapsing-remitting multiple sclerosisJoseph A Chacko, Paolo Strati, Paul W Stout, et al.
Leukemia & Lymphoma|December 31, 2021
Statins enhance the chemosensitivity of R-CHOP in diffuse large B-cell lymphomaSushanth Gouni, Paolo Strati, Gokce Toruner, et al.
Leukemia Research|November 5, 2017
JAK2V617F detection and allele burden measurement in saliva vs. peripheral blood in patients with myelofibrosisPaolo Strati, Christopher B Benton, Taghi Manshouri, et al.
British Journal of Haematology|March 2, 2019
Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphomaTamer Khashab, Fredrick Hagemeister, Jorge E Romaguera, et al.
Cell Reports. Medicine|August 16, 2023
Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cellsPaolo Strati, Xubin Li, Qing Deng, et al.
Research Square|February 24, 2023
Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatmentShuying Liu, Shelly M Xie, Wenbin Liu, et al.
Leukemia & Lymphoma|June 26, 2019
Additional therapy improves outcomes in completely resected, limited-stage follicular lymphomaTherese Y Andraos, Zeina Ayoub, Loretta J Nastoupil, et al.
Pageof 31